By utilizing C. elegans, researchers can gain deeper insights into the mechanisms underlying GNAO1 encephalopathy and develop targeted treatments that address the complex interplay of motor dysfunctions, seizures, and developmental delays characteristic of this disorder. This evidence concerns the gene GNAO1 and Global developmental delay.